Structuring Licensing Deals to Maximise Value and Avoid Costly Mistakes

October 15, 2026
Therapeutics, Diagnostics & Med Device Innovation
For early-stage and growth-stage companies, the structure of a licensing agreement can define future valuation, partnership potential, and commercial success. Getting deal economics, IP, and exclusivity right early is critical to protecting long-term upside while securing the right partners to scale. This session walks through: ' Understanding licensing economics for therapeutics and devices to support early negotiation strategies. ' Structuring agreements that maximize long-term value while protecting core intellectual property. ' Navigating IP and exclusivity complexities that influence commercialization prospects.